Dow Dips 375 Points; S&P 500 Down Over 2%
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 375 points on Friday.
Why Morgan Stanley Shares Are Trading Lower, Here Are 43 Stocks Moving In Friday’s Mid-Day Session
Gainers
Intelligent Living Application Group Inc. (NASDAQ: ILAG) surged 77.7% to $9.35.
Uber, Lyft, AZZ And Other Big Losers From Tuesday
U.S. stocks closed mixed with the Nasdaq Composite dropping more than 100 points on Tuesday. Here is the list of some big stocks recording losses in the previous session.
Zymeworks Reminds Shareholders To Vote FOR Its Redomicile
The Redomicile is anticipated to provide greater opportunities to enhance long-term value for securityholders, simplify commercialization efforts and monetization opportunities for our product candidates, and provide
Wells Fargo Assumes Zymeworks at Overweight, Lowers Price Target of $9
Wells Fargo analyst Nick Abbott assumes Zymeworks (NYSE:ZYME) with a Overweight rating and lowers Price Target of $9.
Zymeworks Announces Filing And Mailing Of Materials For The Special Meeting To Approve Redomicile To Delaware
Redomicile anticipated to enhance long-term value for securityholders, provide opportunities for increased value of Zymeworks common shares, and better position the Company for future growth
Zymeworks Board
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
Citigroup Maintains Buy on Zymeworks, Lowers Price Target to $27
Citigroup analyst Yigal Nochomovitz maintains Zymeworks (NYSE:ZYME) with a Buy and lowers the price target from $28 to $27.
Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell
• Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
Analyst Ratings for Zymeworks
Over the past 3 months, 5 analysts have published their opinion on Zymeworks (NYSE:ZYME) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.